Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Smoking Cessation Benefits and Time-Course of Health Improvements

Immediate Benefits (Within Days to Weeks)

  • Blood carbon monoxide levels normalize within hours to days of cessation, according to the National Comprehensive Cancer Network 1
  • Respiratory symptoms improve rapidly, including reduction in cough and shortness of breath within the first few weeks, as reported by the National Comprehensive Cancer Network 1, 2
  • Lung function begins to improve measurably within the first weeks of cessation, as stated by the National Comprehensive Cancer Network 1

Short-Term Benefits (Weeks to Months)

  • 14 days of preoperative cessation reduces pulmonary complications and in-hospital mortality, as found by the National Comprehensive Cancer Network 2, 3
  • 3 weeks of cessation before reconstructive surgery significantly lowers wound healing complications, according to the National Comprehensive Cancer Network 2
  • Risk-adjusted mortality and complication rates progressively decrease as cessation duration increases from 14 days to 1 month, to 1-12 months, and beyond 12 months, as reported by the National Comprehensive Cancer Network 2

Intermediate Benefits (6-12 Months)

  • Recent quitters demonstrate survival outcomes intermediate between never-smokers and current smokers, as found by the National Comprehensive Cancer Network 2, 3
  • Performance status improves at 6 and 12 months post-diagnosis compared to continued smokers, even after adjusting for disease stage, demographics, therapy, and comorbidity, according to the National Comprehensive Cancer Network 2, 3
  • Overall symptom burden decreases significantly by 6 months after cessation, as reported by the National Comprehensive Cancer Network 2, 5

Long-Term Benefits (1-10+ Years)

  • 1 year quit: Adjusted HR 1.04 (minimal benefit yet), as found by Chest 4
  • 1-5 years quit: Adjusted HR 0.93 (7% risk reduction), according to Chest 4
  • 5-10 years quit: Adjusted HR 0.84 (16% risk reduction), as reported by Chest 4
  • 10+ years quit: Adjusted HR 0.65 (35% risk reduction, linear trend P < .001), according to Chest 4

Cancer-Specific Long-Term Benefits

  • Reduced recurrence rates compared to continued smokers, as found by the National Comprehensive Cancer Network 2, 3
  • Lower rates of second primary cancers in lung and head/neck cancer patients, according to the National Comprehensive Cancer Network 2, 3
  • Former smokers approach never-smoker risk levels for metastasis in colon cancer, as reported by the National Comprehensive Cancer Network 2, 3

Critical Clinical Implications

  • Even quitting after a cancer diagnosis or in middle age provides substantial mortality and morbidity benefits, as stated by the National Comprehensive Cancer Network 1, 2
  • The benefit curve is continuous and progressive—there is no threshold effect, according to Chest 4
  • Stopping smoking after an MI is potentially the most effective of all preventive measures, with benefits that are almost immediate, as found by the European Heart Journal 6